0B68 Trabulsi, Edouard - Thomas Jefferson University - Thomas Jefferson University
ext273

Edouard Trabulsi, MD

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
  2. VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  3. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy
  4. Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
  5. Radiographic Kinetics of Sarcomatoid Renal Cell Carcinoma
  6. Posterior Approach to Robotic-Assisted Laparoscopic Radical Prostatectomy
  7. Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia
  8. Contrast-Enhanced Subharmonic and Harmonic Ultrasound of Renal Masses Undergoing Percutaneous Cryoablation
  9. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience
  10. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  11. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  12. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: Comparative analysis of long-term outcomes
  13. Treatment of Exophytic Renal Cancer Smaller than 3 cm: Surgery versus Active Surveillance
  14. Cutaneous metastasis of micropapillary urothelial carcinoma
  15. Treatment of exophytic renal cancer smaller than 3 cm: surgery versus active surveillance
  16. Surgical management of upper tract urothelial carcinoma-open, laparoscopic, and robotic approaches to nephroureterectomy and outcomes
  17. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
  18. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  19. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: Results of a multicenter phase II study with molecular correlates of response and toxicity
  20. High dose rate brachytherapy boost for prostate cancer: A systematic review
0